NUTRA PHARMA CORP Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nutra Pharma Corp quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2022.
  • Nutra Pharma Corp Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 7.6B shares, a 3.95% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 7.6B +288M +3.95% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 7.59B +319M +4.39% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 7.36B +139M +1.92% Mar 31, 2022 10-Q 2022-05-20
Q4 2021 7.33B +376M +5.4% Dec 31, 2021 10-Q 2022-11-21
Q3 2021 7.31B +563M +8.34% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 7.27B +640M +9.65% Jun 30, 2021 10-Q 2021-09-24
Q1 2021 7.23B +603M +9.1% Mar 31, 2021 10-Q 2021-09-17
Q4 2020 6.96B +1.08B +18.4% Dec 31, 2020 10-K 2022-04-15
Q3 2020 6.75B +1.67B +32.9% Sep 30, 2020 10-Q 2021-08-12
Q2 2020 6.63B +1.59B +31.5% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 6.62B +2.58B +63.7% Mar 31, 2020 10-Q 2021-07-23
Q4 2019 5.88B +1.83B +45.2% Dec 31, 2019 10-K 2021-09-08
Q3 2019 5.08B +1.06B +26.5% Sep 30, 2019 10-Q 2021-05-14
Q2 2019 5.04B +1.8B +55.5% Jun 30, 2019 10-Q 2021-05-07
Q1 2019 4.05B +1.71B +73.5% Mar 31, 2019 10-Q 2021-04-05
Q4 2018 4.05B +2.01B +99.1% Dec 31, 2018 10-K 2021-07-01
Q3 2018 4.01B +2.28B +131% Sep 30, 2018 10-Q 2018-11-19
Q2 2018 3.24B +2.41B +288% Jun 30, 2018 10-Q 2018-08-17
Q1 2018 2.33B +1.96B +533% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 2.03B +1.74B +589% Dec 31, 2017 10-K 2021-02-05
Q3 2017 1.73B +1.51B +660% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 835M +687M +466% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 368M +262M +247% Mar 31, 2017 10-Q 2017-05-17
Q4 2016 295M +215M +270% Dec 31, 2016 10-K 2018-04-17
Q3 2016 228M +157M +220% Sep 30, 2016 10-Q 2016-11-22
Q2 2016 147M +111M +301% Jun 30, 2016 10-Q 2016-08-22
Q1 2016 106M +67.1M +171% Mar 31, 2016 10-Q/A 2016-06-21
Q4 2015 79.8M +43M +117% Dec 31, 2015 10-K 2017-04-17
Q3 2015 71.4M -933M -92.9% Sep 30, 2015 10-Q 2015-11-23
Q2 2015 36.8M -1.23B -97.1% Jun 30, 2015 10-Q 2015-08-18
Q1 2015 39.1M -965M -96.1% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 36.8M -968M -96.3% Dec 31, 2014 10-K 2016-04-14
Q3 2014 1B +79.2M +8.57% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 1.27B +556M +78.1% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 1B +415M +70.4% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 1B +443M +78.8% Dec 31, 2013 10-K 2015-04-13
Q3 2013 925M +543M +142% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 712M +333M +87.7% Jun 30, 2013 10-Q 2013-08-19
Q1 2013 589M +220M +59.5% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 562M +235M +72.1% Dec 31, 2012 10-K 2014-03-31
Q3 2012 383M +77.4M +25.4% Sep 30, 2012 10-Q/A 2012-12-12
Q2 2012 380M +82.4M +27.7% Jun 30, 2012 10-Q/A 2012-12-07
Q1 2012 370M Mar 31, 2012 10-Q/A 2012-11-28
Q4 2011 326M +46.2M +16.5% Dec 31, 2011 10-K 2013-04-16
Q3 2011 305M Sep 30, 2011 10-Q 2011-11-15
Q2 2011 297M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 280M Dec 31, 2010 10-K/A 2012-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.